RTI Surgical® Reaches 5,000 Implant Milestone for Fortilink® Interbody Fusion Systems with TETRAfuse® 3D Technology
June 06 2019 - 7:45AM
RTI Surgical Holdings, Inc. (Nasdaq: RTIX), a global surgical
implant company, today announced a milestone of 5,000 implants
of Fortilink®-C, -TS and -L Interbody Fusion (IBF) Systems with
TETRAfuse® 3D Technology in the United States.
“In my over 500 implantations, I have been extremely satisfied
with the Fortilink-TS and -C IBF devices”, said Dr. Mario Brkaric,
co-founder of the Indiana Spine Center. “I have had no
intra-operative or post-operative issues and have seen no issues
with cage migration. Visualization in the office on postoperative
X-rays has also been great.”
RTI Surgical commercially launched the Fortilink-C IBF System
for use in anterior cervical discectomy and fusion (ACDF) surgeries
in October 2017. It was the first in a family of devices to
incorporate RTI Surgical’s TETRAfuse 3D Technology intended for use
in patients with degenerative disc disease. Following the
successful launch of the Fortilink-C IBF System, the company
commercially launched both the Fortilink-TS and -L IBF Systems with
TETRAfuse 3D Technology to be used in lateral lumbar interbody
fusion (LLIF) and transforaminal lumbar interbody fusion (TLIF) or
bilateral posterior lumbar interbody fusion (PLIF) surgeries,
respectively. Since launch, the Fortilink family of devices has
experienced significant growth in the total number of implants from
Q1 2018 to Q1 2019.
“This milestone of 5,000 implants for the Fortilink family of
devices with TETRAfuse 3D Technology reinforces surgeon confidence
in this award-winning technology,” said Camille Farhat, President
and CEO, RTI Surgical. “Adding to this confidence, we are investing
in our commitment to clinical data through our FORTE study to show
definitive outcomes for patients for pain reduction and procedural
and long-term performance. Our Fortilink series remains a key
platform within our increasingly differentiated spine portfolio
poised to drive growth in Spine for RTI in 2019 and beyond. We are
looking forward to the next milestone as we continue to treat more
patients.”
TETRAfuse 3D Technology is featured in the growing family of
Fortilink IBF devices to help drive optimal outcomes for patients
undergoing spinal fusion procedures. It features a
nano-roughi surface with antibacterial
characteristics†iii designed to participate in fusionii
without compromising mechanical integrityi or radiographic
visibilityi. TETRAfuse 3D Technology recently won a 2019 MedTech
Breakthrough Award for “Best New Technology Solution - Orthopedics”
and a 2018 Spine Technology Award from Orthopedics This Week.
For more information, please visit www.tetrafuse3D.com.
About RTI Surgical Holdings, Inc.
RTI Surgical is a leading global surgical implant company
providing surgeons with safe biologic, metal and synthetic
implants. Committed to delivering a higher standard, RTI’s implants
are used in spine, sports medicine, general surgery, orthopedic and
trauma procedures and are distributed in nearly 50 countries. RTI
has four manufacturing facilities throughout the U.S. and Europe.
RTI is accredited in the U.S. by the American Association of Tissue
Banks and is a member of AdvaMed. For more information,
visit www.rtix.com. Connect with us
on LinkedIn and Twitter.
Steven Cohen Media Contact scohen@rtix.com +1
847 648 0861
Molly Poarch Investor Contact mpoarch@rtix.com
+1 224 287 2661
References
i Data on file at RTI Surgical, Inc.
ii Data on file at RTI Surgical, Inc. Performance data from
animal studies may not be representative of performance in
humans.
iii Wang M, Bhardwaj B, Webster T; Antibacterial properties
of PEKK for orthopedic applications. Int’l Journal of Nanomedicine.
2017: 12 6471-6476.
† Lab data may not be representative of the effects with
all bacteria or performance when implanted in humans.
Staphyloccocus epidermidis and Pseudomonas aeruginosa were subject
bacterial strains in this study.
Please refer to the labeling for clinical applications,
warnings, precautions and other instructions for use.
RTI Surgical (NASDAQ:RTIX)
Historical Stock Chart
From Aug 2024 to Sep 2024
RTI Surgical (NASDAQ:RTIX)
Historical Stock Chart
From Sep 2023 to Sep 2024